What is KTTA stock price today?

Visit our real-time dashboard for the current KTTA stock price and live market data.

Is KTTA stock going up or down today?

KTTA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KTTA stock now?

The decision to buy KTTA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KTTA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KTTA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KTTA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KTTA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KTTA's P/E ratio?

P/E ratio data for KTTA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KTTA's market cap?

KTTA (Pasithea Therapeutics Corp) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is KTTA's price to book ratio?

Price-to-book ratio for KTTA is available on our dashboard along with other valuation metrics.

Does KTTA pay dividends?

KTTA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KTTA's dividend yield?

KTTA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KTTA stock a good long-term investment?

KTTA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KTTA's revenue growth rate?

Revenue growth data for KTTA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for KTTA are available on our dashboard with complete income statement analysis.

What are the risks of investing in KTTA?

Key risks for KTTA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KTTA compare to its competitors?

Compare KTTA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KTTA's performance and positioning.

What is KTTA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for KTTA with bull, base, and bear case scenarios.

What do analysts say about KTTA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KTTA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KTTA's next earnings report?

KTTA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KTTA - Pasithea Therapeutics Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Pasithea Therapeutics Corp

Pasithea Therapeutics Corp (KTTA) common stock

Price Chart

Loading chart...

KTTA Key Statistics

Market Cap

$5.65M

How KTTA Compares to Peers

KTTA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
KTTA(This stock)	$5.65M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 3:20 PM EDT

Ready to invest in KTTA?

Commission-free trading available. Affiliate links.

Upcoming Events for KTTA

Dashboard

Enter a ticker to analyze